Quizartinib (AC220) is a potent second generation class III tyrosine kinase inhibitor that displays a distinct inhibition profile against mutant-FLT3, -PDGFRA and -KIT isoformsKerstin Maria Kampa-Schittenhelm, Marcus M. Schittenhelm|Molecular Cancer|2013Cited by 121
Dronabinol has preferential antileukemic activity in acute lymphoblastic and myeloid leukemia with lymphoid differentiation patternsKerstin Maria Kampa-Schittenhelm, Marcus M. Schittenhelm|BMC Cancer|2016Cited by 33